Revenue

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

Transamerica's new AI assistant, Pearl, promises to cut retirement account consolidation from weeks to days. Is this the future of personal finance?

SafeRack's new modular gangway promises one-week installation and enhanced safety, challenging industry norms for efficiency and worker protection.

A new one-time gene therapy shows it can clear toxic brain plaques in preclinical studies, offering a potential path to halt or even reverse Alzheimer's.

Following a key acquisition, biosolutions giant Novonesis leverages strong investor confidence to secure long-term financing for its strategic market expansion.

The CRM provider launched a visual lead management tool to help agents organize prospects, automate follow-ups, and convert more deals.

The company advances a new transport system for advanced reactor fuel, a crucial step in a competitive race to build the future nuclear supply chain.

Aspen Group reports a fourth straight profitable quarter through deep cost cuts, but its future growth hinges on a looming debt deadline and a major merger.

The near-commercial lithium company adds a retired Marine general and a top policy architect to navigate Washington's critical minerals strategy.

Jet.AI and its partner advance their massive Canadian data center projects, securing natural gas and renewable energy to fuel the future of artificial intelligence.

D-ID's new V4 agents promise hyper-realistic, real-time AI conversations at a fraction of the cost, pushing the boundaries of human-AI interaction.

Atlanta's Monarch Private Capital is channeling billions into energy, housing, and film. We explore the strategy and impact of this powerful financial engine.

In a bid to reshape the AI hardware market, Celestica and AMD are joining forces on an open-standards platform to compete with established players.

Pactum's new Requisition Alignment Agent automates compliance and negotiation in enterprise systems, promising huge savings and a new role for human buyers.

As FullPAC sponsors the 2026 Pollie Awards, its focus on AI and a planned public listing reveal a strategy to reshape how elections are won.

The firm posted a massive $66M profit, but a $77M non-cash gain and a move to OTC markets urge investors to look beyond the impressive headlines.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

The San Francisco Giants' new deal with Athletic Brewing brings NA beer to Oracle Park, signaling a major shift in sports and mindful drinking.

ShengShu Technology's new AI tool promises to revolutionize animated series, but can it overcome the hurdles of consistent storytelling at scale?